Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh · Delayed Price · Currency is BDT 212.10
-0.70 (-0.33%)
At close: Apr 13, 2026
DSE:SQURPHARMA Market Cap
DSE:SQURPHARMA has a market cap or net worth of 188.02 billion as of April 14, 2026. Its market cap has decreased by -1.90% in one year.
Market Cap
188.02B
Enterprise Value
118.06B
Revenue
81.95B
Ranking
n/a
PE Ratio
7.25
Stock Price
212.10
Market Cap Chart
Since April 18, 2002, DSE:SQURPHARMA's market cap has increased from 3.10B to 188.02B, an increase of 5,960.16%. That is a compound annual growth rate of 18.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 188.02B | 6.80% |
| Dec 30, 2025 | 176.05B | -8.77% |
| Dec 30, 2024 | 192.98B | 3.52% |
| Dec 28, 2023 | 186.42B | 0.24% |
| Dec 29, 2022 | 185.98B | -2.10% |
| Dec 30, 2021 | 189.97B | -2.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 52.37B |
| Renata | 48.21B |
| Unilever Consumer Care | 40.74B |
| Beacon Pharmaceuticals | 22.66B |
| The ACME Laboratories | 16.00B |
| Asiatic Laboratories | 10.66B |
| The IBN SINA Pharmaceutical Industry | 9.84B |
| Orion Pharma | 6.55B |